Momentum Bioscience

7 Decision Makers · 7 Verified Contacts & Email Format

📍 Reading, Reading, United KingdomBiotechnology🗓 Est. 2005👥 11–50 employees

About Momentum Bioscience

Momentum Bioscience develops enzyme mediated amplification solutions for the rapid detection of pathogens in blood and sterile fluids.

Email Format

{first_letter_first_name}{last_name}@momentumbio.co.uk — 100.0%

ssmith@momentumbio.co.uk

Leadership & Decision Makers

Contact details of 7 Momentum Bioscience decision makers

Matthew Crow

Head of R&D
  • Work email

    m***w@momentumbio.co.uk

    Verified

Sumi Thaker

CEO
  • Work email

    s*****r@momentumbio.co.uk

    Verified

Bill Mullen

Founder
  • Work email

    b*****n@momentumbio.co.uk

    Verified

Jim Thurlow

Consulting Chief Operating Officer

David Evans

Chairman

John Hockley

Head of Operations

Jim Heath

Founder

General Emails

General company emails, e.g. customer support lines

    info@momentumbio.co.uk

    General Inquiries

    ninfo@momentumbio.co.uk

    General Inquiries

    bmullen@momentumbio.co.uk

    Unclassified inbox

Similar Companies like Momentum Bioscience

Cullinan Oncology

cullinanoncology.com
Pharmaceuticals · Cambridge, MA · Est. 2017 · 11–50 employees

HQ: Cambridge, MA

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Adimab

adimab.com
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees

HQ: Lebanon, New Hampshire, United States

Loxo Oncology

loxooncology.com
Pharmaceuticals · New York, NY · Est. 2013 · 501–1000 employees

HQ: New York, NY

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 31/07/2025

44 1189 357 344

Reading, Reading, United Kingdom

Legal Name: Momentum Bioscience Ltd
Business Type: Private
Employees: 11-50
Rounds: Series B
Founded Date: 2005
Company Type: For Profit
Operating Status: Active
Last Funding Type: Series B
Phone Number: 44 1189 357 344
Last Investment Activity: Jul 4, 2024
Investments Activity: Jul 4, 2024 Jul 17, 2015 Mar 14, 2014

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.